Mark J. Truty

8.2k citations

196 papers · 4.8k indexed · 2 hit papers · h-index 36

Impact in

Oncology top 0.5%
- Pancreatic and Hepatic Oncology Research
Hepatology top 1%
- Hepatocellular Carcinoma Treatment and Prognosis

Papers in

Oncology 135
- Pancreatic and Hepatic Oncology Research 105
Surgery 98
- Cholangiocarcinoma and Gallbladder Cancer Studies 36
- Pancreatitis Pathology and Treatment 32

Co-authors: Michael L. Kendrick David M. Nagorney Rory L. Smoot Michael B. Farnell Florencia G. Que Jean‐Nicolas Vauthey Raúl Urrutia KMarie Reid‐Lombardo
Journals: HPB (20 papers)Annals of Surgical Oncology (16 papers)Journal of Gastrointestinal Surgery (14 papers)Journal of the American College of Surgeons (14 papers)Surgery (13 papers)
Partner nations: United States Japan China

In The Last Decade

Mark J. Truty

183 papers receiving 4.7k citations

Hit Papers

align trajectories log scale

Factors Predicting Response, Perioperative Outcomes, and Survival Following Total Neoadjuvant Therapy for Borderline/Locally Advanced Pancreatic Cancer 2019 · 284 citations

Peers

Countries citing papers authored by Mark J. Truty

Since Specialization

Citations

This map shows the geographic impact of Mark J. Truty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark J. Truty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark J. Truty more than expected).

Fields of papers citing papers by Mark J. Truty

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark J. Truty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark J. Truty. The network helps show where Mark J. Truty may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark J. Truty, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark J. Truty Line = papers co-authored together Mark J. Truty links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Liver resection following neoadjuvant immunotherapy: a single center retrospective study Updates in Surgery ·أمانی عبد العال, Liélma Carla Chagas da Silva, Evawati Evawati, Cornelius A. Thiels, Susanne G Warner, Mark J. Truty, Michael L. Kendrick, Rory L. Smoot, David M. Nagorney, Patrick Starlinger	2025	0
2	Contemporary Advances, Evidence, and Considerations in Preoperative Therapy for Pancreatic Ductal Adenocarcinoma Seminars in Radiation Oncology ·Alexander D. Sherry, 戴余金, Ryan M. Carr, Mark J. Truty, Krishan R. Jethwa	2025	0
3	The Influence of Area Deprivation Index on Surgical Outcomes in Pancreas Cancer Journal of Surgical Oncology ·Hala Muaddi, Amy E. Glasgow, Mohamad K. Abou Chaar, Elizabeth B. Habermann, Patrick Starlinger, Susanne G. Warner, Rory L. Smoot, Michael L. Kendrick, Mark J. Truty, Cornelius A. Thiels	2024	1
4	YAP ‐ TEAD inhibition is associated with upregulation of an androgen receptor mediated transcription program providing therapeutic escape FEBS Open Bio ·Luis Fernando Arias Vargas, Denise De Almeida, Waqas Ahmed, Jennifer A. Yonkus, Amro M. Abdelrahman, Caitlin B. Conboy, Erik Jessen, Nathan W. Werneburg, 厚一砂田, Luca Pagliarulo, Gregory J. Gores, Sumera I. Ilyas, Mark J. Truty, He T	2024	1
5	Second-line therapies in advanced hepatocellular carcinoma following first-line atezolizumab and bevacizumab: multicenter single institution cohort experience The Oncologist ·Kamada Yoshihiko, William Sbrama Perressim, Jennifer Gile, YU Jianl, Emily Lukaka, Hani M. Babiker, I Dewa Ketut Wicaksana, Mason Brown, Rondell P. Graham, Mark J. Truty, Patrick Starlinger, Þorvarður R. Hálfdánarson, Zhaohui Jin, Aminah Jatoi, Robert R. McWilliams, Mitesh J. Borad, Tanios Bekaii‐Saab, Amit Mahipal, Fang‐Shu Ou, Nguyen H. Tran	2024	1
6	A Novel ypTLM Staging System Based on LODDS for Gastric Cancer After Neoadjuvant Therapy: Multicenter and Large‐Sample Retrospective Study World Journal of Surgery ·Zachary J. McLaughlin, Qing Zhong, Qi‐Yue Chen, Mark J. Truty, Su Yan, Yu‐Bin Ma, 温德成, Chao‐Hui Zheng, Ping Li, Jia‐Bin Wang, Jian‐Xian Lin, Jun Lü, Long‐Long Cao, Mi Lin, Ru‐Hong Tu, Ju‐Li Lin, Hua‐Long Zheng, Chang‐Ming Huang	2023	1
7	Oncologic Outcomes of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Highly Selected Patients with Metastatic Pancreatic Ductal Adenocarcinoma Annals of Surgical Oncology ·Hallbera Gudmundsdottir, Jennifer A. Yonkus, Cornelius A. Thiels, Susanne G. Warner, Sean P. Cleary, Michael L. Kendrick, Mark J. Truty, Travis E. Grotz	2023	5
8	Mixed Acinar Neuroendocrine Carcinoma of the Pancreas: Comparative Population-Based Epidemiology of a Rare and Fatal Malignancy in The United States Cancers ·Amro M. Abdelrahman, Jun Yin, Luis Fernando Arias Vargas, Jennifer A. Yonkus, Jennifer L. Leiting, 栄純李, Kiana Roshan Zamir, Thamires Barcelos Tosta, Oriana Casasola, Lewis R. Roberts, Gregory J. Gores, Rory L. Smoot, Rondell P. Graham, Þorvarður R. Hálfdánarson, Mark J. Truty	2023	1
9	Cytoreduction with Hyperthermic Intraperitoneal Chemoperfusion for Pancreatic Cancer with Low-Volume Peritoneal Metastasis: Results from a Prospective Pilot Study Annals of Surgical Oncology ·Travis E. Grotz, Jennifer A. Yonkus, Cornelius A. Thiels, Susanne G. Warner, Robert R. McWilliams, Amit Mahipal, Tanios Bekaii‐Saab, Sean P. Cleary, Michael L. Kendrick, Mark J. Truty	2022	6
10	Patterns of Recurrence After Primary Local Therapy for Pancreatic Ductal Adenocarcinoma – A Critical Review of Rationale and Target Delineation for (Neo)Adjuvant Radiation Therapy Practical Radiation Oncology ·Krishan R. Jethwa, Shane S. Neibart, Mark J. Truty, Salma K. Jabbour, Christopher L. Hallemeier	2022	9
11	Optimizing Nanopore Sequencing for Rapid Detection of Microbial Species and Antimicrobial Resistance in Patients at Risk of Surgical Site Infections mSphere ·Fikry Fauzi, Jennifer A. Yonkus, Patricio Jeraldo, Luis Fernando Arias Vargas, Heidi Nelson, Michael L. Kendrick, Thomas E. Grys, Robin Patel, Mark J. Truty, Nicholas Chia	2022	21
12	Tyrosine Phosphoproteomics of Patient-Derived Xenografts Reveals Ephrin Type-B Receptor 4 Tyrosine Kinase as a Therapeutic Target in Pancreatic Cancer Cancers ·Santosh Renuse, Vijay Sagar Madamsetty, Dong‐Gi Mun, Anil K. Madugundu, Shauna Quin, Neda Goshayesh, Kiran K. Mangalaparthi, Min‐Sik Kim, Ren Liu, Sunil Kumar, Valery Krasnoperov, Mark J. Truty, Rondell P. Graham, Parkash S. Gill, Debabrata Mukhopadhyay, Akhilesh Pandey	2021	4
13	Outcomes of pancreatectomy with portomesenteric venous resection and reconstruction for locally advanced pancreatic neuroendocrine neoplasms HPB ·Hallbera Gudmundsdottir, Waqas Ahmed, Rondell P. Graham, Cornelius A. Thiels, Susanne G. Warner, Rory L. Smoot, Michael L. Kendrick, David M. Nagorney, Þorvarður R. Hálfdánarson, Elizabeth B. Habermann, Mark J. Truty, Sean P. Cleary	2021	3
14	Cancer imaging and therapy utilizing a novel NIS-expressing adenovirus: The role of adenovirus death protein deletion Molecular Therapy — Oncolytics ·Li‐Li Zheng, Penny Coltman, Eriko Iguchi, Stanislav O. Zakharkin, Christopher J. LaRocca, Ezequiel J. Tolosa, Mark J. Truty, S. Engel Michael, Martín E. Fernández-Zapico, Julia Davydova	2021	10
15	Multifocality is not associated with worse survival in sporadic pancreatic neuroendocrine tumors Journal of Surgical Oncology ·Hallbera Gudmundsdottir, Rondell P. Graham, Mohamad Bassam Sonbol, Rory L. Smoot, Mark J. Truty, Michael L. Kendrick, David M. Nagorney, Elizabeth B. Habermann, Þorvarður R. Hálfdánarson, Sean P. Cleary	2021	5
16	YAP Tyrosine Phosphorylation and Nuclear Localization in Cholangiocarcinoma Cells Are Regulated by LCK and Independent of LATS Activity Molecular Cancer Research ·Takaaki Sugihara, Nathan W. Werneburg, Matthew C. Hernandez, Lin Yang, Ayano Kabashima, Petra Hirsova, Lavanya Yohanathan, Carlos Sosa, Mark J. Truty, George Vasmatzis, Gregory J. Gores, Rory L. Smoot	2018	84
17	Radiation Therapy for Retroperitoneal Sarcomas: Influences of Histology, Grade, and Size Sarcoma ·Jennifer L. Leiting, John R. Bergquist, Matthew C. Hernandez, Kenneth W. Merrell, Andrew L. Folpe, Steven I. Robinson, David M. Nagorney, Mark J. Truty, Travis E. Grotz	2018	10
18	Transforming Growth Factor-β Limits Secretion of Lumican by Activated Stellate Cells within Primary Pancreatic Adenocarcinoma Tumors Clinical Cancer Research ·Ya’an Kang, David Roife, Yeon‐Ju Lee, 宏一松尾, Rei Suzuki, Jianhua Ling, Dendy Syaiful Akbar, Xinqun Li, Bingbing Dai, Michael Pratt, Mark J. Truty, Deyali Chatterjee, Huamin Wang, Ryan M. Thomas, Yu Wang, Eugene J. Koay, Paul J. Chiao, Matthew H. G. Katz, Jason B. Fleming	2016	29
19	Integrated Genomic Analysis of Pancreatic Ductal Adenocarcinomas Reveals Genomic Rearrangement Events as Significant Drivers of Disease Cancer Research ·Stephen J. Murphy, Steven N. Hart, Geoffrey C. Halling, Sarah H. Johnson, James B. Smadbeck, Travis Drucker, Joema Felipe Lima, Gustavo Herrera Cortez, Faye R. Harris, Farhad Kosari, Subbaya Subramanian, Gloria M. Petersen, Timothy D. Wiltshire, Benjamin R. Kipp, Mark J. Truty, Robert R. McWilliams, Fergus J. Couch, George Vasmatzis	2015	25
20	Pancreatic Cancer–Derived Exosomes Cause Paraneoplastic β-cell Dysfunction Clinical Cancer Research ·Naureen Javeed, Gunisha Sagar, Shamit K. Dutta, Thomas C. Smyrk, Julie S. Lau, Santanu Bhattacharya, Mark J. Truty, Gloria M. Petersen, Randal J. Kaufman, Suresh T. Chari, Debabrata Mukhopadhyay	2014	150

About Mark J. Truty

Mark J. Truty is a scholar working on Oncology, Surgery, Hepatology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 196 papers that have together received 4.8k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (105 papers), Neuroendocrine Tumor Research Advances (39 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (36 papers), Pancreatitis Pathology and Treatment (32 papers), Gallbladder and Bile Duct Disorders (22 papers), Cancer Genomics and Diagnostics (20 papers), Gastric Cancer Management and Outcomes (18 papers) and Renal cell carcinoma treatment (16 papers). The work is most often cited by research in Oncology (2.9k citations), Hepatology (641 citations), Surgery (2.3k citations), Pulmonary and Respiratory Medicine (1.6k citations) and Cancer Research (692 citations). Mark J. Truty has collaborated with scholars based in United States, Japan and China. Frequent co-authors include Michael L. Kendrick, David M. Nagorney, Rory L. Smoot, Michael B. Farnell, Florencia G. Que, Jean‐Nicolas Vauthey, Raúl Urrutia, KMarie Reid‐Lombardo, Sean P. Cleary and John R. Bergquist. Their work appears in journals such as HPB, Annals of Surgical Oncology, Journal of Gastrointestinal Surgery, Journal of the American College of Surgeons and Surgery.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact